Ovarian Brenner tumors and Walthard nests: a histologic and immunohistochemical study
Tài liệu tham khảo
Lee, 2003, Tumors of the ovary and peritoneum, 113
Scully, 1998, Atlas of tumor pathology, 153
Seidman, 2008, Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors, Arch Pathol Lab Med, 132, 1753, 10.5858/132.11.1753
Kuhn, 2013, Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium, Eur J Cancer, 49, 3839, 10.1016/j.ejca.2013.08.011
Stohr, 1956, The relationship of the Brenner tumor to the rete ovarii, Am J Obstet Gynecol, 72, 389, 10.1016/0002-9378(56)90125-9
Logani, 2003, Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications, Am J Surg Pathol, 27, 1434, 10.1097/00000478-200311000-00005
Cuatrecasas, 2009, Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas, Am J Surg Pathol, 33, 556, 10.1097/PAS.0b013e318188b84c
Soslow, 1996, Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis, Int J Gynecol Pathol, 15, 257, 10.1097/00004347-199607000-00011
Esheba, 2009, Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations, Am J Surg Pathol, 33, 347, 10.1097/PAS.0b013e3181908e24
Grote, 2006, Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney, Development, 133, 53, 10.1242/dev.02184
Ordóñez, 2013, Value of GATA3 immunostaining in tumor diagnosis: a review, Adv Anat Pathol, 20, 352, 10.1097/PAP.0b013e3182a28a68
Nonaka, 2013, A study of gata3 and phox2b expression in tumors of the autonomic nervous system, Am J Surg Pathol, 37, 1236, 10.1097/PAS.0b013e318289c765
Miettinen, 2014, GATA3: A multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors, Am J Surg Pathol, 38, 13, 10.1097/PAS.0b013e3182a0218f
Roma AA. Mesonephric carcinosarcoma involving uterine cervix and vagina. Report of two cases with immunohistochemical positivity for PAX2, PAX8 and GATA-3. Int J Gynecol Pathol (in press).
Roma, 2014, Differential expression pattern of GATA3 among mesonephric lesions and endocervical and endometrial adenocarcinomas, Mod Pathol, 27, 303A
Bowen, 2007, Emerging roles for PAX8 in ovarian cancer and endosalpingeal development, Gynecol Oncol, 104, 331, 10.1016/j.ygyno.2006.08.052
Laury, 2011, A comprehensive analysis of PAX8 expression in human epithelial tumors, Am J Surg Pathol, 35, 816, 10.1097/PAS.0b013e318216c112
Tong, 2009, Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study, Mod Pathol, 22, 1218, 10.1038/modpathol.2009.88
Cao, 2009, SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma, Am J Surg Pathol, 33, 894, 10.1097/PAS.0b013e318198177d
Cao, 2009, SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors, Cancer, 115, 2640, 10.1002/cncr.24308
Silva, 2012, The stromal origin of some epithelial ovarian neoplasms: “fere ex nihilo”, Int J Gynecol Cancer, 22, 906, 10.1097/IGC.0b013e31824ebba7
Laury, 2010, PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma, Am J Surg Pathol, 34, 627, 10.1097/PAS.0b013e3181da7687
Nomura, 1997, A histogenetic consideration of ovarian mucinous tumors based on an analysis of lesions associated with teratomas or Brenner tumors, Pathol Int, 47, 862, 10.1111/j.1440-1827.1997.tb03718.x